Anti-Hepatitis B Virus Surface Antigen (Ad/Ay) 抗体 (ab9193)
Key features and details
- Horse polyclonal to Hepatitis B Virus Surface Antigen (Ad/Ay)
- Suitable for: ELISA
- Reacts with: Hepatitis B virus
- Isotype: IgG
製品の概要
-
製品名
Anti-Hepatitis B Virus Surface Antigen (Ad/Ay) antibody
Hepatitis B Virus Surface Antigen (Ad/Ay) 一次抗体 製品一覧 -
製品の詳細
Horse polyclonal to Hepatitis B Virus Surface Antigen (Ad/Ay) -
由来種
Horse -
特異性
This antibody is specific for Hepatitis B surface antigen -
アプリケーション
適用あり: ELISAmore details -
種交差性
交差種: Hepatitis B virus -
免疫原
Immunization of horses with highly purified Ad/Ay antigen.
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
pH: 7.20
Constituents: 0.0268% PBS, 0.87% Sodium chloride -
Concentration information loading...
-
精製度
Affinity purified -
特記事項(精製)
This antibody was immunoaffinity purified from non-recombinant hepatitis antigens. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Conjugation kits
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab9193の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ELISA |
Use at an assay dependent concentration.
|
特記事項 |
---|
ELISA
Use at an assay dependent concentration. |
ターゲット情報
-
関連性
Hepatitis B Virus (HBV) infection induces a disease state characterised by liver damage, inflammation and viral persistence. Infection also increases the risk of hepatocellular carcinoma. HBV belongs to the Hepadnaviridae family of viruses. Its genome consists of partially double stranded circular DNA. The DNA is enclosed in a nucleocapsid, or core antigen (HBcAg), which is surrounded by a spherical envelope (surface antigen or HBsAg). The core antigen shares its sequences with the e antigen (HBeAg) but no cross reactivity between the two proteins has been observed. The HBV genome also encodes a DNA polymerase that also acts as a reverse transcriptase. Hepatitis B infection is normally diagnosed from serological tests that detect HBsAg but as the disease progresses this antigen may no longer be present in the blood and tests for HBcAg are used. If HBsAg can be detected in the blood for longer than six months, chronic hepatitis B is diagnosed. The antigenic determinant of the protein moiety of the HBsAg determines specific characteristics of different serotypes and provides the basis of immunodetection. HBsAg has antigenic heterogeneity, specifically, two pairs of sub specific determinants, d/y and w/r allow the following combinations: adw, ayw, adr, ayr. -
細胞内局在
Virion membrane -
参照データベース
- Entrez Gene: 2828293 Hepatitis B virus
- Entrez Gene: 944569 Hepatitis B virus
- SwissProt: P03138 Hepatitis B virus
- SwissProt: P03140 Hepatitis B virus
- SwissProt: P03141 Hepatitis B virus
- SwissProt: Q81157 Hepatitis B virus
- SwissProt: Q81158 Hepatitis B virus
- SwissProt: Q81159 Hepatitis B virus
see all -
別名
- HBsAg antibody
- HBV major surface antigen antibody
- HBV surface antigen antibody
see all
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (32)
ab9193 は 32 報の論文で使用されています。
- Aoki-Utsubo C et al. Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells. Microbiol Immunol 67:281-292 (2023). PubMed: 36929353
- Angelo L et al. Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen. PLoS One 18:e0293167 (2023). PubMed: 37910550
- Ou G et al. Host sex disparity and viral genotype dependence of the glycosylation level of small Hepatitis B surface protein in patients with HBeAg-positive chronic Hepatitis B. Virol J 20:159 (2023). PubMed: 37468949
- Popescu MA et al. Sac1 phosphatidylinositol 4-phosphate phosphatase is a novel host cell factor regulating hepatitis B virus particles assembly and release. FEBS J 289:7486-7499 (2022). PubMed: 35816160
- Zhang J et al. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells. Virol J 19:28 (2022). PubMed: 35144643